GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GSK Pharmaceuticals has published newspaper advertisements informing shareholders about the mandatory transfer of shares to the Investor Education and Protection Fund (IEPF). This affects shareholders who have not encashed dividend warrants for the financial year 2018-19 for seven consecutive years. The company has already sent individual communications to affected shareholders dated 27th May 2026. Shareholders have until 31st July 2026 to claim their unpaid dividends from the Registrar (KFin Technologies), failing which shares will be transferred to IEPF. After transfer, shareholders can reclaim shares and dividends by applying to IEPF in Form IEPF-5.
This is routine regulatory compliance under the Companies Act with no direct impact on GSK's stock price or financials. Affected shareholders who wish to retain their shares must act before the deadline.